The clinical significance of serum procalcitonin levels following direct hemoperfusion with polymyxin B-immobilized fiber column in septic patients with colorectal perforation

European Surgical Research

Volumn 42, Issue 2, 2009, Pages 109-117

  Shimizu, T ^a   Hanasawa, K ^a   Sato, K ^b   Umeki, M ^c   Koga, N ^d   Naganuma, T ^f   Sato, S ^e   Shimonishi, T ^g   Ikeda, T ^h   Matsuno, N ^h   Ono, S ^j   Saitoh, H ^k   Satoh, K ⁱ   Otani, Y ^l   Endo, Y ^a   Eguchi, Y ^a   Tani, T ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^c HYOGO PREFECTURAL AWAJI HOSPITAL   (Japan)

^d Shinkoga Hospital

^e SAGA UNIVERSITY HOSPITAL   (Japan)

^f SAISEIKAI MATSUSAKA GENERAL HOSPITAL   (Japan)

^g Takagi Hospital   (Japan)

^h TOKYO MEDICAL UNIVERSITY   (Japan)

ⁱ Higashiyamato Hospital   (Japan)

^j NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^k KANAZAWA MEDICAL UNIVERSITY   (Japan)

^l Sagamidai Hospital   (Japan)

more..

Author keywords

Adsorption; Endotoxin; PMX; Sepsis; Septic shock; Toraymyxin

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; ENDOTOXIN; INTERLEUKIN 6; POLYMYXIN B; PROCALCITONIN;

AGED; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COLON PERFORATION; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; FATALITY; FEMALE; HEMOPERFUSION; HUMAN; MALE; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PARATHYROID HORMONE BLOOD LEVEL; PERITONEUM; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SURVIVOR; TREATMENT RESPONSE;

AGED; ANTI-BACTERIAL AGENTS; CALCITONIN; COLONIC DISEASES; ENDOTOXINS; FEMALE; HEMOPERFUSION; HUMANS; INTERLEUKIN-6; INTESTINAL PERFORATION; MALE; PERITONEAL DISEASES; POLYMYXIN B; PROSPECTIVE STUDIES; PROTEIN PRECURSORS; RECTAL DISEASES; SEPSIS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 58149101573     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000187169     Document Type: Article

References (44)

1. Beutler B: Science review: key inflammatory and stress pathways in critical illness - the central role of the Toll-like receptors. Crit Care 2003;7:39-46.
2. Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): are we winning the battle? Shock 1998;10:79-89.
3. Rivers E: The outcome of patients presenting to the emergency department with severe sepsis or septic shock. Crit Care 2006;10:154.
4. Suliburk J, Helmer K, Moore F, Mercer D: The gut in systemic inflammatory response syndrome and sepsis: enzyme systems fighting multiple organ failure. Eur Surg Res 2008;40:184-189.
5. Marra MN, Thornton MB, Snable JL, Wilde CG, Scott RW: Endotoxin-binding and -neutralizing properties of recombinant bactericidal/ permeability- increasing protein and monoclonal antibodies HA-1A and E5. Crit Care Med 1994;22:559-565.
6. Bosch T: Recent advances in therapeutic apheresis. J Artif Organs 2003;6:1-8.
7. Bhor VM, Thomas CJ, Surolia N, Surolia A: Polymyxin B: an ode to an old antidote for endotoxic shock. Mol Biosyst 2005;1:213-222.
8. Aoki H, Kodama M, Tani T, Hanasawa K: Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber. Am J Surg 1994;167:412-417.
9. Tani T, Hanasawa K, Kodama M, Imaizumi H, Yonekawa M, Saito M, Ikeda T, Yagi Y, Takayama K, Amano I, Shimaoka H, Ohta M, Okahisa T, Koga N, Fujita N, Yamasa H: Correlation between plasma endotoxin, plasma cytokines, and plasminogen activator inhibitor-1 activities in septic patients. World J Surg 2001;25:660-668.
10. Sato T, Shoji H, Koga N: Endotoxin adsorption by polymyxin B immobilized fiber column in patients with systemic inflammatory response syndrome: the Japanese experience. Ther Apher Dial 2003;7:252-258.
11. Shimizu T, Endo Y, Tsuchihashi H, Akabori H, Yamamoto H, Tani T: Endotoxin apheresis for sepsis. Transfus Apher Sci 2006;35:271-282.
12. Ronco C: The place of early haemoperfusion with polymyxin B fibre column in the treatment of sepsis. Crit Care 2005;9:631-633.
13. Vincent JL, Laterre PF, Cohen J, Burchardi H, Bruining H, Lerma FA, Wittebole X, De BD, Brett S, Marzo D, Nakamura H, John S: A pilot-controlled study of a polymyxin B-immobilized hemoperfusion cartridge in patients with severe sepsis secondary to intra-abdominal infection. Shock 2005;23:400-405.
14. Cruz DN, Perazella MA, Bellomo R, Polanco N, de Cal M, Polanco N, Corradi V, Nalesso F, Lentini P, Ueno T, Ranieri VM, Ronco C: Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review. Crit Care 2007;11:R47.
15. Kojika M, Sato N, Yaegashi Y, Suzuki Y, Suzuki K, Nakae H, Endo S: Endotoxin adsorption therapy for septic shock using polymyxin B-immobilized fibers (PMX): evaluation by high-sensitivity endotoxin assay and measurement of the cytokine production capacity. Ther Apher Dial 2006;10:12-18.
16. Maruna P, Nedelnikova K, Gurlich R: Physiology and genetics of procalcitonin. Physiol Res 2000;49:S57-S61.
17. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-518.
18. Ito S, Sato N, Kojika M, Yaegashi Y, Suzuki Y, Suzuki K, Endo S: Serum procalcitonin levels are elevated in esophageal cancer patients with postoperative infectious complications. Eur Surg Res 2005;37:22-28.
19. Kin H, Kawazoe K, Nakajima T, Niinuma H, Kataoka T, Endo S, Inada K: Perioperative serum procalcitonin concentrations in patients with acute aortic dissection. Eur Surg Res 2003;35:451-454.
20. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret GY: Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34:1996-2003.
21. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
22. Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001;345:1368-1377.
23. Dellinger RP: Cardiovascular management of septic shock. Crit Care Med 2003;31:946-955.
24. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004;32:858-873.
25. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, Reinhart CK, Suter PM, Thijs LG: The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707-710.
26. Tani T, Hanasawa K, Endo Y, Yoshioka T, Kodama M, Kaneko M, Uchiyama Y, Akizawa T, Takahasi K, Sugai K: Therapeutic apheresis for septic patients with organ dysfunction: hemoperfusion using a polymyxin B immobilized column. Artif Organs 1998;22:1038-1044.
27. Shimizu T, Tani T, Hanasawa K, Endo Y, Kodama M: The role of bacterial translocation on neutrophil activation during hemorrhagic shock in rats. Shock 2001;16:59-63.
28. Yamada H, Matsuda S, Ushio Y, Nakamura K, Kobatake S, Satomura S, Matsuura S: Determination of procalcitonin concentration using the SphereLight 180 clinical auto-analyzer. Clin Chim Acta 2008;388:38-40.
29. Bellomo R, Ronco C: Blood purification in the intensive care unit: evolving concepts. World J Surg 2001;25:677-683.
30. Nemoto H, Nakamoto H, Okada H, Sugahara S, Moriwaki K, Arai M, Kanno Y, Suzuki H: Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif 2001;19:361-368.
31. Kushi H, Miki T, Nakahara J, Okamoto K, Kawahara Y, Saito T, Tanjoh K: Hemoperfusion with an immobilized polymyxin B fiber column reduces circulating interleukin-8 concentrations. Ther Apher Dial 2006;10:425-429.
32. Matsuno N, Ikeda T, Ikeda K, Hama K, Iwamoto H, Uchiyama M, Kozaki K, Narumi Y, Kikuchi K, Degawa H, Nagao T: Changes of cytokines in direct endotoxin adsorption treatment on postoperative multiple organ failure. Ther Apher 2001;5:36-39.
33. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, Limburg PC, ten Duis HJ, Moshage H, Hoekstra HJ, Bijzet J, Zwaveling JH: Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000;28:458-461.
34. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, Jager L, Reinhart K: Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999;134:49-55.
35. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, Bohuon C: Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-1608.
36. Dahaba AA, Hagara B, Fall A, Rehak PH, List WF, Metzler H: Procalcitonin for early prediction of survival outcome in postoperative critically ill patients with severe sepsis. Br J Anaesth 2006;97:503-508.
37. Rau B, Kruger CM, Schilling MK: Procalcitonin: improved biochemical severity stratification and postoperative monitoring in severe abdominal inflammation and sepsis. Langenbecks Arch Surg 2004;389:134-144.
38. Reith HB, Mittelkotter U, Debus ES, Kussner C, Thiede A: Procalcitonin in early detection of postoperative complications. Dig Surg 1998;15:260-265.
39. Novotny A, Emmanuel K, Matevossian E, Kriner M, Ulm K, Bartels H, Holzmann B, Weighardt H, Siewert JR: Use of procalcitonin for early prediction of lethal outcome of postoperative sepsis. Am J Surg 2007;194:35-39.
40. Rau BM, Frigerio I, Buchler MW, Wegscheider K, Bassi C, Puolakkainen PA, Beger HG, Schilling MK: Evaluation of procalcitonin for predicting septic multiorgan failure and overall prognosis in secondary peritonitis: a prospective, international multicenter study. Arch Surg 2007;142:134-142.
41. Hanasawa K, Tani T, Oka T, Yoshioka T, Aoki H, Endo Y, Kodama M: Selective removal of endotoxin from the blood by extracorporeal hemoperfusion with polymyxin B immobilized fiber. Prog Clin Biol Res 1988;264:337-341.
42. Hanasawa K, Tani T, Kodama M: New approach to endotoxic and septic shock by means of polymyxin B immobilized fiber. Surg Gynecol Obstet 1989;168:323-331.
43. Jaber BL, Barrett TW, Cendoroglo NM, Sundaram S, King AJ, Pereira BJ: Endotoxin removal by polymyxin-B immobilized polystyrene-derivative fibers during in vitro hemoperfusion of 10% human plasma. ASAIO J 1998;44:54-61.
44. Hussein MH, Kato T, Sugiura T, Daoud GA, Suzuki S, Fukuda S, Sobajima H, Kato I, Togari H: Effect of hemoperfusion using polymyxin B-immobilized fiber on IL-6, HMGB-1, and IFN gamma in a neonatal sepsis model. Pediatr Res 2005;58:309-314.